Abstracts of the Final Year Projects of Pharm D Clinical Pharmacy Students, Faculty of Pharmacy, Beni-Suef University, Year 2024/2025

June 2025 in “ International Journal of Clinical Medical Research ”

Beni-suef University Clinical Pharmacy Department Faculty of Pharmacy

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pharaohacademy.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community All Drugs in Clinical Trials in 2023

in Research/Science 68 upvotes 3 years ago

12 companies having drugs or therapies in clinical trials during 2023, with various molecules and phases of trial; the probability that some may fail; and progress being made in the field.

community PP405 (Non) Update - Feb 2025

in Research/Science 34 upvotes 1 year ago

The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.

community Pelage have presented only phase 2a. The rest of phase 2 for PP405 will be presented at a later medical meeting

in Chat 30 upvotes 1 month ago

PP405's phase 2a trial results were presented, focusing on safety and pharmacokinetics, with a future meeting planned to share the full dataset. The trial includes a randomized controlled portion and an open-label extension, with no indication of phase 2B completion.

community PP405 2a study was a safety study. Some rational explaining.

in Research/Science 22 upvotes 8 months ago

The conversation discusses the safety study of PP405, emphasizing that early trials focus on safety rather than efficacy, and that any efficacy data from such a short study should be viewed skeptically. It also highlights that the information released is primarily for securing funding, and that meaningful efficacy results are expected in later phases.

community is there any news about pp405 please

in Update 11 upvotes 1 year ago

There is no new information on pp405, with data collection expected to finish by the end of 2025. Users are discussing the timeline for data analysis and completion of Pelage Pharmaceuticals' phase 2 study.

community Are we still getting the PP405 phase 2a results by the end of March?

in Research/Science 27 upvotes 2 months ago

People are discussing the anticipated release of PP405 phase 2a results, expected by the end of March, with some skepticism about its effectiveness. There is cautious optimism due to past experiences with similar treatments like Breezula, despite concerns about the lack of presentation at the AAD 2026 conference.

Similar Research

5 / 1000+ results

research Abstracts

October 2020 in “Veterinary Dermatology”

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Straight Hair Associated with Interferon-Alpha Plus Ribavirin in Hepatitis C Infection

research Straight hair associated with interferon-alfa plus ribavirin in hepatitis C infection

34 citations , August 2002 in “British Journal of Dermatology”

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

research Polarized microscopy in genetic hair disorders: case series

January 2025

Polarized microscopy helps identify hair irregularities in genetic disorders.

research Abstracts from the 4th Annual Student Medical Summit

1 citations , May 2021 in “BMC Proceedings”

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

research Clinical efficacy of silk sericin dressing with collagen for split-thickness skin graft donor site treatment

January 2021

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.